The Reliability and Validity of the Turkish Version of the Occupational Sitting and Physical Activity Questionnaire

January 22, 2021 updated by: Saime Nilay Arman, Istanbul University

The Reliability and Validity of the Turkish Version of the Occupational Sitting and Physical Activity Questionnaire in Office Workers

The aim of our study is to investigate the validity and reliability of the Occupational Sitting And Physical Activity Questionnaire (OSPAQ) scale in Turkish by making a cultural adaptation in office workers, which was developed to evaluate work-related sitting, standing, walking and doing heavy work. 100 office workers will be included in the study. Physical activity level of office workers will be evaluated with Turkish OSPAQ and International Physical Activity Questionnaire.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Unknown

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Detailed Description

It is reported that those who do desk work in working life act less as a result of their professional requirements. Considering the benefits of physical activity, it is recommended that the risks of desk workers, especially those in the risk group who produce work by consuming less energy, should be reduced and encouraged to participate in physical activity at a level and manner suitable for a healthier life. For this reason, it is important to determine the level of physical activity according to different variables in individuals working at desk jobs.The aim of our study is to evaluate the validity and reliability of the "Occupational Sitting And Physical Activity Questionnaire (OSPAQ)" scale in Turkish, which was developed to evaluate the situation of sitting, standing, walking and doing heavy work. All forms will be sent through the media. 100 office workers will be included in the study. Physical activity level of office workers will be evaluated by Turkish OSPAQ and International Physical Activity Questionnaire. For the reliability study, after 7 days, the physical activity of office workers will be re-evaluated with Turkish OSPAQ. Factor analysis methods will be used to examine the factor structure of the scale, correlation analysis (Pearson and Spearman coefficients) in validity analysis and test-retest reliability. Cronbach alpha analysis will be used in the reliability analysis.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
100

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

20 years to 45 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

1000 office workers residing in Turkey will be contacted via e-mail and social media. Participants who agree to participate in the study via Google forms will be able to answer the questions. The individuals who volunteers and meets the inclusion criteria will be included in the study. at least 100 office workers will be included in the present study.

Description

Inclusion Criteria:

  • Being in the age range of 20-45 Being resident in Turkey Working at a desk job for at least one year Using a computer for at least 4-5 hours a day at work Volunteering to participate in the study

Exclusion Criteria:

  • Exercising regularly for the last 2 months Having a cardiac, neurological or rheumatic chronic disease Being pregnant

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
"Occupational Sitting And Physical Activity Questionnaire (OSPAQ)''
Time Frame: Change from baseline to 7 day
The OSPAQ is a brief instrument to record the proportion of work time spent sitting, standing, walking, and doing heavy labour, as well as the total length of time worked in the past five working days. Participants will be asked to indicate the percentage of time spent on those activities during working hours on a typical working day. The participants will be received a slightly adjusted instruction to fill in the OSPAQ compared to other studies, namely to keep in mind a typical working day instead of the last seven working days (i.e. "How would you describe a typical working day in your current job? This only includes your working day. Commuting and everything outside the work setting is not included."). So when accumulating all percentages a total percentage of 100 was obtained: for example, 55% occupational sitting, 25% walking, 15% standing, and 5% performing heavy labour.
Change from baseline to 7 day
International physical activity questionnaire short form
Time Frame: Change from baseline to 7 day
The IPAQ has since become the most widely used physical activity questionnaire, with two versions available: the 31 item long form (IPAQ-LF) and the 9 item short form (IPAQ-SF). The short form records the activity of four intensity levels: 1) vigorous-intensity activity such as aerobics, 2) moderate-intensity activity such as leisure cycling, 3) walking, and 4) sitting. The original authors recommended the "last 7 day recall" version of the IPAQ-SF for physical activity surveillance studies, in part because the burden on participants to report their activity is small.
Change from baseline to 7 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Istanbul University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 30, 2021

Primary Completion (ANTICIPATED)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
February 25, 2021

Study Completion (ANTICIPATED)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
May 30, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
January 20, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 20, 2021

First Posted (ACTUAL)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 22, 2021

Study Record Updates

Last Update Posted (ACTUAL)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 26, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 22, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 11971

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings